Patents
Patents for C07K 1 - General processes for the preparation of peptides (51,718)
02/2007
02/22/2007WO2007020886A1 Protein refolding agent and refolding method
02/22/2007WO2006130736A3 High quantum yield acridinium compounds and their uses in improving assay sensitivity
02/22/2007WO2006097694A3 Peptide synthesis supported by a soluble polymer
02/22/2007WO2006085984A3 Immune cell biosensors and methods of using same
02/22/2007WO2006084007A3 Novel gene underlying atherosclerosis locus i
02/22/2007WO2006076025A9 Immune cell biosensors and methods of using same
02/22/2007WO2005111060A3 Molecules involved in protein folding and methods op identifying them
02/22/2007WO2004048543A3 Methods and compositions for controlling valency of phage display
02/22/2007US20070043207 6-Chlorobenzotriazol-1-yloxytriaminophosphonium salts (6-chiorobenzotriazol-1-yloxytris(pyrrolidino)phosphonium hexafluorophosphate); highly reactive; peptide synthesis
02/22/2007US20070042944 purification of fibrinogen; loading a solution with fibrinogen and other proteins onto an immobilized metal ion affinity chromatography matrix under conditions such that the fibrinogen and the protein both bind to the matrix, and selectively eluting the fibrinogen; provide a lyophilized product
02/22/2007US20070042460 Oxidation of peptides
02/22/2007US20070042431 Methods for reducing complexity of a sample using small epitope antibodies
02/22/2007US20070042383 for detecting Mycobacterium paratuberculosis in a sample using nucleic acid molecules, polypeptides, and antibodies; for immunization and prevention of mycobacterial animal infections
02/22/2007US20070039823 Fluid injection system
02/22/2007US20070039822 Direct determination of carbohydrates amino acids and antibiotics by microchip electrophoresis with pulsed amperometric detection
02/22/2007CA2619004A1 Improved microfitration devices
02/22/2007CA2618791A1 Novel mucin-type glycoprotein and use thereof
02/22/2007CA2618066A1 Differentially protected orthogonal lanthionine technology
02/21/2007EP1753778A1 Method for purifying erythropoietin
02/21/2007EP1753458A2 Modulation of immunoglobulin production and atopic disorders
02/21/2007EP1753450A1 Process for the isolation and/or purification of proteins
02/21/2007EP1753441A2 Polypeptides for inducing a protective immune response against staphylococcus aureus
02/21/2007EP1534404B1 Use of a clathrate modifier to promote passage of proteins during nanofiltration
02/21/2007EP1328546B1 Cyclic peptides, method for preparing same and use as angiogenesis inhibitor or activator
02/21/2007EP1280545B1 Cross-linked collagen matrices and methods for their preparation
02/21/2007EP1200179B8 Charged filtration membranes and uses therefor
02/21/2007CN1918176A Polypeptides for inducing a protective immune response against staphylococcus aureus
02/21/2007CN1917900A Erysipelothrix rhusiopathiae-haemophilus parasuis vaccine and methods of using the same
02/21/2007CN1916172A Method for preparing parathormone 1-34
02/21/2007CN1916018A Method for producing mucus protein of sweet potato from wastewater of sweet potato f
02/21/2007CN1916017A Process for producing hydrophobic polypeptides, proteins or peptides.
02/21/2007CN1301264C Oxidation resistant bioactive peptide of halobios and preparation method
02/20/2007US7179895 Rat calcium channel subunits and related probes, cell lines and methods
02/20/2007US7179890 Polypeptides as angiogenesis inhibitors
02/20/2007US7179889 Propionicin T1 polypeptide, a bacteriocin from Propionibacterium thoenii
02/20/2007US7179835 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors
02/20/2007US7179795 Nucleic acids encoding chimeric proteins comprising BMP-2 and a proteinase inhibitor
02/20/2007US7179793 Fish protein hydrolysates (Salmo or Oncorhynchus); for inhibiting angiotensin converting enzyme
02/20/2007US7179786 Variants of the NK1 fragment of hepatocyte growth factor/scatter factor (HGF/SF) and their use
02/20/2007US7179635 Peptides for use in culture media
02/20/2007US7179623 Method of producing amino acids using E. coli transformed with sucrose PTS genes
02/20/2007US7179618 Streptavidin proteins
02/20/2007US7179617 Forming a convalent conjugate of a Factor IX peptide, removing X2 or a saccharyl subunit thereof from peptide forming a truncated glycan; contacting truncated glycan with glycosyltransferase and modified sugar donor under conditions suitable for glycosyltransferase to transfer a modified sugar moiety
02/20/2007US7179611 Purification; isoelectric precipitation; analyzing
02/20/2007CA2346997C Cytotoxic lymphocyte maturation factor and monoclonal antibodies directed thereto
02/20/2007CA2309312C The process for preparing octreotide and derivatives thereof
02/15/2007WO2007018877A2 Downhole uses of electroactive polymers
02/15/2007WO2007018759A2 Ligand-binding reagents for quenching and improved purification of lipidated proteins
02/15/2007WO2007017637A1 Method for producing recombinant interferon alpha-8
02/15/2007WO2007017087A1 Process for the preparation of crystalline perindopril
02/15/2007WO2007016971A1 Fluidic analysis with hydrophobic and hydrophilic compounds trapping
02/15/2007WO2006128163A3 Transgenic alzheimer's mouse model vectors and uses thereof
02/15/2007WO2006104964A3 Inhibition of wet type age related macular degeneration (amd) by adiponectin or acrp 30
02/15/2007WO2006081584A3 Electrically controlled microfluidic system
02/15/2007WO2006011151A3 Vaccine comprising recombinant ct or lt toxin
02/15/2007WO2005003289A8 Ap1 amine oxidase variants
02/15/2007US20070037967 conjugated by bridging molecules to proteins or polypeptides, reporter groups or cytotoxic agents; cancer
02/15/2007US20070037964 Chemoselective ligation
02/15/2007US20070037963 Differentially protected orthogonal lanthionine technology
02/15/2007US20070036720 Radiolabelled metal transport protein as imaging agent
02/15/2007CA2617271A1 Downhole uses of electroactive polymers
02/15/2007CA2615691A1 Process for the preparation of crystalline perindopril
02/14/2007EP1752469A2 Long lasting fusion peptide inhibitors for HIV infection
02/14/2007EP1752466A2 Process of purification of hcg and recombinant hcg purified by that method
02/14/2007EP1752465A2 Linear VH-CH1-VH-CH1 heavy chain antibody fragment
02/14/2007EP1752160A2 Epitope sequences
02/14/2007EP1751312A2 Polymorphism in tryptophan hydroxylase-2 controls brain serotonin synthesis
02/14/2007EP1751174A1 Inhibitors of regiii proteins as asthma therapeutics
02/14/2007EP1670813A4 Rho antibody and tag to purify cell surface proteins
02/14/2007EP1451206B1 Process for the selective alkylation of -sh groups in proteins and peptides for the study of complex protein mixtures
02/14/2007EP1442059B1 Analogs of human growth hormone-releasing hormone, their preparation and use
02/14/2007EP1200577B1 In vitro selection and optional identification of polypeptides using solid support carriers
02/14/2007EP1035780B1 Method for purifying heat shock peptides complexes
02/14/2007EP1009726B1 Fluorination of proteins and peptides for f-18 positron emission tomography
02/14/2007CN1914223A Modified human interferon polypeptides and their uses
02/14/2007CN1911955A Preparation method of black bone chicken active peptide
02/14/2007CN1300171C Preparation of myocardium peptide
02/14/2007CN1300169C Method for refining sheep placenta active component using membrane separating technology
02/14/2007CN1300168C Solid carrier based on linking agent for peptide and small molecular organic synthesis
02/13/2007US7176286 Antigen fragments for the diagnosis of Toxoplasma gondii
02/13/2007US7176285 Ligands for human protein histidine phosphatase (PHP1); identifying agonists and antagonists and treating conditions associated with PHPIP-120 imbalance with the identified compounds; cardiovascular disorders; autism; schizophrenia; antiarthritic and -carcinogenic agents; Bardet-Beidl Syndrome; anemia
02/13/2007US7176280 Isolated polypeptides and compositions from the venom of P. transvaalicus and methods of use
02/13/2007US7176245 Block copolymer processing for mesostructured inorganic oxide materials
02/13/2007US7176181 Enhancement or inhibition of the interactions of galectin-8 and galectin-8-like proteins with other extracellular matrix proteins or cell surface receptors; the use of modulators of cell adhesion; antitumor, -carcinogenic, -metastasis agents
02/13/2007US7176037 Labeled peptides, proteins and antibodies and processes and intermediates useful for their preparation
02/13/2007US7176006 Comprises nucleotide sequences coding hydrolase for prodrug therapy; drug screening; drug delivery; detoxification
02/13/2007US7175993 Taxol immunoassay
02/13/2007US7175767 Preparation of a metal chelating separation medium
02/13/2007US7175747 Immobilized to support; diffusion
02/13/2007CA2510981C Fibrin sealant compositions and methods for utilizing same
02/13/2007CA2165781C Process for producing relaxin
02/08/2007WO2007016272A1 Method and system for in vitro protein folding
02/08/2007WO2007016250A1 Method of purifying protein
02/08/2007WO2007014447A1 Gelation of undenatured proteins with polysaccharides
02/08/2007US20070032961 Apparatus and method for automated protein design
02/08/2007US20070032638 Method for the purification of a non-immunoglobulin protein comprising an immunoglobulin-like (ig-like) domain
02/08/2007US20070031930 Includes lowering the pH of a whole E coli cell solution to form an acidic solution, disrupting the cells to release the protein into the acidic solution, and separating the cellular debris from the released protein to obtain a protein product enriched in the heterologous target protein
02/08/2007US20070031877 Support for analyte determination methods and method for producing the support
02/08/2007US20070031368 Chemokine conjugates
02/08/2007US20070029198 For microchips; polymer solution (N-isopropylacrylamide homo- or copolymer in water) that is optically transparent below a critical solution temperature and turbid at or above that temperature; apparatus with tubes containing the solution can measure temperature at wide surface and interior areas